Peter Angus, Pharm.D., PhD - Director of Analytical

Scientific Leadership

 

Peter Angus, Pharm.D., Ph.D.

 

Peter Angus, Pharm.D., Ph.D., Director of Pharmaceutical Chemistry for Velesco Pharmaceutical Services

As the Director of Pharmaceutical Chemistry for Velesco Pharmaceutical Services, Peter brings over a decade of experience working in the pharmaceutical industry. He has an extensive background in analytical method development and validation, cleaning verification and validation, project and laboratory management and management of analytical support for clinical supplies manufacturing for Phase I and Phase II clinical trials. 

 

His pharmaceutical industry experience extends across numerous types of drug product formulations including: standard immediate release capsule and tablet formulations; extended/delayed release formulations; softgel capsule formulations (encapsulations); tablets and capsules containing spray dried dispersions, spray layered dispersions, microbeads, hot-melt extrusions, spray-layered beads; IV solutions, and extemporaneously prepared solutions. Furthermore, Peter has expertise in early-stage topical, IV, and oral vehicle drug formulations for delivery of low solubility compounds.

Peter joined Velesco after working for in the Pharmaceutical Sciences Division of Pfizer Global Research & Development, and several years working for Pharmacia and G.D. Searle in Analytical Development. While at Pfizer, he served as the scientific lead and technical expert for a GMP product release laboratory. Peter was also responsible for managing a group of analytical scientists and numerous scientific and technical projects supporting development of compounds from discovery to Phase III.

 

 

He holds a Pharm.D. from the University of Michigan and a Ph.D. in Pharmaceutical Chemistry from the University of Kansas.

News and Events

Velesco Pharma will be closed Tuesday, December 24, 2019 through Wednesday, January 1, 2020.

 

Lisa Crandall, MS, and Peter Angus, PhD, spoke with Pharmaceutical Technology about the best practices in stability testing.  Read the interview here.

 

                                                                              Velesco has expanded our analytical facilities in a new Wixom, Michigan location with the help of the Bank of Ann Arbor Technology Industry Group.                          Read the press release here.

  

CEO Dave Barnes has been published in a new Pharmoutsourcing article on Clinical Trial Materials and Manufacturing

  

2 new job postings! Careers 

  

Velesco's work published 

  Formulation Development & Manufacturing:

Using a Single Provider Reduces Costs & Risk

Read it here.

  

Follow Velesco: 

 LinkedIn IN Icon 25px Google+ Follow VelescoPharma on Twitter  FB FindUsOnFacebook 100

 

734-274-9877